At the news
? NEUTRALIMPACT 3/10 DEFA14A filed Apr 24, 2026 at 16:08 ET
Analysis based on filing metadata only, document content was unavailable
- Filing is a DEFA14A (Definitive Additional Materials) for 10x Genomics, Inc. (TXG)
- Filing type indicates it contains proxy statement materials, likely related to a shareholder vote
- No actual document content was provided to analyze the specific matters being voted on
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access